Hypertension and Angiotensin System Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Hypertension and Angiotensin System Inhibitors: Impact on Outcome in Sunitinib-Treated Patients for Metastatic Renal Cell Carcinoma
Ann. Oncol 2015 Jun 01;26(6)1128-1133, H Izzedine, L Derosa, G Le Teuff, L Albiges, B EscudierFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.